We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNCH
1151
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$150K ﹤0.01%
+1,766
New +$151K
MGYR icon
1152
Magyar Bancorp
MGYR
$123M
$149K ﹤0.01%
12,579
– –
HOWL icon
1153
Werewolf Therapeutics
HOWL
$19.6M
$148K ﹤0.01%
+36,211
New +$165K
CTHR
1154
DELISTED
Charles & Colvard Ltd
CTHR
$147K ﹤0.01%
11,889
– –
INAB icon
1155
IN8bio
INAB
$9.55M
$146K ﹤0.01%
2,000
– –
TBHC
1156
DELISTED
The Brand House Collective
TBHC
$146K ﹤0.01%
41,500
– –
BLZE icon
1157
Backblaze
BLZE
$1.12B
$144K ﹤0.01%
+27,500
New +$206K
GANX icon
1158
Gain Therapeutics
GANX
$75.9M
$144K ﹤0.01%
40,000
– –
LODE icon
1159
Comstock
LODE
$235M
$142K ﹤0.01%
22,900
– –
CGTX icon
1160
Cognition Therapeutics
CGTX
$101M
$141K ﹤0.01%
66,200
-10,000
-13% -$25.8K
LGF.A
1161
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$140K ﹤0.01%
15,000
-75,000
-83% -$916K
MCHX icon
1162
Marchex
MCHX
$80.2M
$138K ﹤0.01%
104,600
-37,400
-26% -$70.1K
PLUR icon
1163
Pluri
PLUR
$19.5M
$138K ﹤0.01%
14,075
+5,325
+61% +$65.5K
UBFO
1164
DELISTED
United Security Bancshares
UBFO
$138K ﹤0.01%
+18,100
New +$141K
ALR
1165
DELISTED
AlerisLife Inc
ALR
$138K ﹤0.01%
114,800
-25,000
-18% -$40.6K
TPHS
1166
DELISTED
Trinity Place Holdings Inc.com
TPHS
$137K ﹤0.01%
135,900
-14,300
-10% -$18.7K
RNWK
1167
DELISTED
RealNetworks Inc
RNWK
$137K ﹤0.01%
216,900
– –
HNNA icon
1168
Hennessy Advisors
HNNA
$78.4M
$136K ﹤0.01%
13,000
– –
REVB icon
1169
Revelation Biosciences
REVB
$4.38M
$135K ﹤0.01%
+1
New +$148K
FSRD
1170
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$135K ﹤0.01%
+215,000
New +$158K
BOLT icon
1171
Bolt Biotherapeutics
BOLT
$7.44M
$134K ﹤0.01%
3,275
-2,500
-43% -$97.1K
WWR icon
1172
Westwater Resources
WWR
$51.9M
$134K ﹤0.01%
123,700
+20,200
+20% +$26.3K
YELL
1173
DELISTED
Yellow Corporation Common Stock
YELL
$134K ﹤0.01%
45,655
– –
KRRO icon
1174
Korro Bio
KRRO
$175M
$133K ﹤0.01%
1,774
– –
AQST icon
1175
Aquestive Therapeutics
AQST
$492M
$131K ﹤0.01%
204,356
-64,200
-24% -$85.4K
45 46
47
48 49

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.